PGL-1 and LID-1 antibody levels in HIV-infected and HIV-uninfected individuals in a Hansen's disease (leprosy) endemic area of Brazil

Brunela Pitanga Madureira; Fernanda Marques de Carvalho; Maria Cristina Pessolani; Simon Michael Collin; Patrícia Duarte Deps

doi:10.1016/j.imbio.2019.11.001

PGL-1 and LID-1 antibody levels in HIV-infected and HIV-uninfected individuals in a Hansen's disease (leprosy) endemic area of Brazil

Brunela Pitanga Madureira, Fernanda Marques de Carvalho, Maria Cristina Pessolani, Simon Michael Collin, Patrícia Duarte Deps

Bristol Medical School (PHS)

Research output: Contribution to journal › Article (Academic Journal) › peer-review

2 Citations (Scopus)

Abstract

Serological tests for subclinical Mycobacterium leprae infection based on antibodies to phenolic glycolipid-1 (PGL-1) and leprosy IDRI diagnostic-1 (LID-1) have not been compared in HIV-infected and uninfected individuals. PGL-1 seropositivity by ELISA was 6.0 % (21/350) in HIV-infected compared with 29.1 % (102/350) in HIV-uninfected individuals (p < 0.001); LID-1 seropositivity was 45.4 % (159/350) in HIV-infected compared with 50.3 % (153/304) in HIV-uninfected individuals (p = 0.21). In HIV-infected individuals, LID-1 but not PGL-1 antibody levels were inversely associated with CD4+ cell count (p = 0.02). These differential associations of HIV infection and CD4 count with PGL-1 and LID-1 have implications for M leprae immunodiagnostic tools and require replication.

Original language	English
Pages (from-to)	151866
Journal	Immunobiology
Early online date	10 Nov 2019
DOIs	https://doi.org/10.1016/j.imbio.2019.11.001
Publication status	E-pub ahead of print - 10 Nov 2019

Bibliographical note

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.imbio.2019.11.001

Handle.net

Persistent link

Cite this

@article{32fe0ce8db6248579b74fffecc24a70b,

title = "PGL-1 and LID-1 antibody levels in HIV-infected and HIV-uninfected individuals in a Hansen's disease (leprosy) endemic area of Brazil",

abstract = "Serological tests for subclinical Mycobacterium leprae infection based on antibodies to phenolic glycolipid-1 (PGL-1) and leprosy IDRI diagnostic-1 (LID-1) have not been compared in HIV-infected and uninfected individuals. PGL-1 seropositivity by ELISA was 6.0 % (21/350) in HIV-infected compared with 29.1 % (102/350) in HIV-uninfected individuals (p < 0.001); LID-1 seropositivity was 45.4 % (159/350) in HIV-infected compared with 50.3 % (153/304) in HIV-uninfected individuals (p = 0.21). In HIV-infected individuals, LID-1 but not PGL-1 antibody levels were inversely associated with CD4+ cell count (p = 0.02). These differential associations of HIV infection and CD4 count with PGL-1 and LID-1 have implications for M leprae immunodiagnostic tools and require replication.",

author = "Madureira, {Brunela Pitanga} and {de Carvalho}, {Fernanda Marques} and Pessolani, {Maria Cristina} and Collin, {Simon Michael} and Deps, {Patr{\'i}cia Duarte}",

year = "2019",

month = nov,

day = "10",

doi = "10.1016/j.imbio.2019.11.001",

language = "English",

pages = "151866",

journal = "Immunobiology",

issn = "0171-2985",

publisher = "Elsevier",

}

TY - JOUR

T1 - PGL-1 and LID-1 antibody levels in HIV-infected and HIV-uninfected individuals in a Hansen's disease (leprosy) endemic area of Brazil

AU - Madureira, Brunela Pitanga

AU - de Carvalho, Fernanda Marques

AU - Pessolani, Maria Cristina

AU - Collin, Simon Michael

AU - Deps, Patrícia Duarte

PY - 2019/11/10

Y1 - 2019/11/10

N2 - Serological tests for subclinical Mycobacterium leprae infection based on antibodies to phenolic glycolipid-1 (PGL-1) and leprosy IDRI diagnostic-1 (LID-1) have not been compared in HIV-infected and uninfected individuals. PGL-1 seropositivity by ELISA was 6.0 % (21/350) in HIV-infected compared with 29.1 % (102/350) in HIV-uninfected individuals (p < 0.001); LID-1 seropositivity was 45.4 % (159/350) in HIV-infected compared with 50.3 % (153/304) in HIV-uninfected individuals (p = 0.21). In HIV-infected individuals, LID-1 but not PGL-1 antibody levels were inversely associated with CD4+ cell count (p = 0.02). These differential associations of HIV infection and CD4 count with PGL-1 and LID-1 have implications for M leprae immunodiagnostic tools and require replication.

AB - Serological tests for subclinical Mycobacterium leprae infection based on antibodies to phenolic glycolipid-1 (PGL-1) and leprosy IDRI diagnostic-1 (LID-1) have not been compared in HIV-infected and uninfected individuals. PGL-1 seropositivity by ELISA was 6.0 % (21/350) in HIV-infected compared with 29.1 % (102/350) in HIV-uninfected individuals (p < 0.001); LID-1 seropositivity was 45.4 % (159/350) in HIV-infected compared with 50.3 % (153/304) in HIV-uninfected individuals (p = 0.21). In HIV-infected individuals, LID-1 but not PGL-1 antibody levels were inversely associated with CD4+ cell count (p = 0.02). These differential associations of HIV infection and CD4 count with PGL-1 and LID-1 have implications for M leprae immunodiagnostic tools and require replication.

U2 - 10.1016/j.imbio.2019.11.001

DO - 10.1016/j.imbio.2019.11.001

M3 - Article (Academic Journal)

C2 - 31757558

SN - 0171-2985

SP - 151866

JO - Immunobiology

JF - Immunobiology

ER -

PGL-1 and LID-1 antibody levels in HIV-infected and HIV-uninfected individuals in a Hansen's disease (leprosy) endemic area of Brazil

Abstract

Bibliographical note

UN SDGs

Access to Document

Handle.net

Fingerprint

Cite this